CDK4/6 INHIBITOR

Clinical trials for CDK4/6 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new CDK4/6 INHIBITOR trials appear

Sign up with your email to follow new studies for CDK4/6 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

Real-World study tracks breast cancer relapses after targeted therapy

Knowledge-focused Recruiting now

This study is observing 750 women and men with a common type of breast cancer (HR+/HER2-) who had a relapse after taking CDK4/6 inhibitors (abemaciclib or ribociclib) as part of their initial treatment. Researchers want to learn more about the characteristics of these relapses an…

Matched conditions: CDK4/6 INHIBITOR

Sponsor: European Institute of Oncology • Aim: Knowledge-focused

Last updated May 17, 2026 00:53 UTC

CDK4/6 INHIBITOR

Get alerted when new CDK4/6 INHIBITOR trials appear

Real-World study tracks breast cancer relapses after targeted therapy